Bosulif Prescribing & Dosing Schedule

Q: What is the dosage of Bosulif?

Bosulif is available in 5 dosages, including 100 mg Cap, 100 mg Tab, 400 mg Tab, 50 mg Cap and 500 mg Tab

Q: What does Bosulif treat?

Bosulif treats BCR-ABL Positive Chronic Myelogenous Leukemia

Q: What is Bosulif made of?

Bosulif contains bosutinib which is a Kinase Inhibitor

Q: How is Bosulif administered?

Bosulif is administered as a Oral Pill

Q: What is Bosulif mechanism of action?

Bosulif mechanism of action is Bcr-Abl Tyrosine Kinase Inhibitors

Dosage & Administration Drug label Samples Prior authorization Pharmacy Financial assistance Patient education People also ask

Bosulif (bosutinib)

Bosulif 50 MG Oral Capsule

NO BOXED WARNING

Dosage & Administration

* Adult patients with newly-diagnosed chronic phase Ph+ CML: 400 mg orally once daily with food.
* Adult patients with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy: 500 mg orally once daily with food.
* Pediatric patients with newly-diagnosed chronic phase Ph+ CML: 300 mg/m2 orally once daily with food.
* Pediatric patients with chronic phase Ph+ CML with resistance or intolerance to prior therapy: 400 mg/m2 orally once daily with food.
* Consider dose escalation by increments of 100 mg once daily to a maximum of 600 mg daily in adult patients who do not reach complete hematologic, cytogenetic, or molecular response and do not have Grade 3 or greater adverse reactions.
* Consider dose escalation by increments of 50 mg for those with a BSA <1.1 m2 and 100 mg for those with a BSA ≥1.1 m2 to a maximum of 600 mg daily in pediatric patients who do not reach sufficient response after 3 months.
* Adjust dosage for toxicity and organ impairment

Bosulif Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

samples

Request Bosulif Samples

Online Sample Form

Learn More

prior authorization

Bosulif Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeal

Formulary Exception Letter

Appeals Checklist

PA Checklist

Appeals Checklsit

Benefits investigation

Pfizer Oncology Together Form

Pfizer Oncology Together Form - Spanish

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

pharmacy

Bosulif Preferred Pharmacy

Pharmacy List

financial assistance

Bosulif Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

HCP Office : Attest & Print Co-Pay Card

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Pfizer Oncology Together Form

Pfizer Oncology Together Form - Spanish

Pfizer Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Bosulif Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link